Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Christopher Gallagher

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Menopause (New York, N.Y.)|October 9, 2019
Sodas and colas are associated with an increase in fracturesJohn Christopher Gallagher
Menopause (New York, N.Y.)|April 15, 2015
Letter to the editorJohn Christopher Gallagher
Expert Opinion on Pharmacotherapy|October 8, 2013
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopauseSri Harsha Tella, John Christopher Gallagher
Expert Opinion on Pharmacotherapy|September 26, 2014
Efficacy of desvenlafaxine succinate for menopausal hot flashesSri Harsha Tella, John Christopher Gallagher
Menopause (New York, N.Y.)|June 18, 2014
Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older womenJohn Christopher Gallagher, Lynette M Smith, Vinod Yalamanchili
Menopause (New York, N.Y.)|May 2, 2013
Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogensJohn Christopher Gallagher, Harry Shi, Sebastian Mirkin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Menopause (New York, N.Y.)|October 9, 2019
Sodas and colas are associated with an increase in fracturesJohn Christopher Gallagher
Menopause (New York, N.Y.)|April 15, 2015
Letter to the editorJohn Christopher Gallagher
Expert Opinion on Pharmacotherapy|October 8, 2013
Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopauseSri Harsha Tella, John Christopher Gallagher
Expert Opinion on Pharmacotherapy|September 26, 2014
Efficacy of desvenlafaxine succinate for menopausal hot flashesSri Harsha Tella, John Christopher Gallagher
Menopause (New York, N.Y.)|June 18, 2014
Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older womenJohn Christopher Gallagher, Lynette M Smith, Vinod Yalamanchili
Menopause (New York, N.Y.)|May 2, 2013
Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogensJohn Christopher Gallagher, Harry Shi, Sebastian Mirkin, et al.
Pageof 1